Cancer patients with dementia less likely to achieve a 'good death'

As the population ages, the number of cancer patients with dementia has increased. A recent study published in Geriatrics & Gerontology International found that cancer patients with dementia were less likely to achieve a "good death" than those without.

In the study, quality of death was measured from nurses' reports and factored in life completion, place of death, and symptom management.

Of the 508 patients with cancer in the study, 156 (30.7%) had dementia. Dementia was associated with a reduced quality of death among patients.

The study's authors note that it may be difficult to confirm patients' end-of-life preferences because of cognitive decline. Their findings point to the importance of enhancing end-of-life care discussions with patients and their families.

In order to provide high quality of end-of-life care, we should facilitate end-of-life care discussions and improve symptom management especially for cancer patients with dementia."

Kayo Hirooka, RN, PhD, lead author, Keio University, in Japan

Source:
Journal reference:

Hirooka, K., et al. (2020) Impact of dementia on quality of death among cancer patients: An observational study of home palliative care users. Geriatrics & Gerontology International. doi.org/10.1111/ggi.13860.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Neoantigen DNA vaccines improve survival and immunity in triple-negative breast cancer patients